Skip to content
drillr.ai
Sign up

PCSA

Processa Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.06
+0.49%
Ask drillr

  • Jul 29, 2026, 12:48 UTC

    Processa Pharmaceuticals raised $200 million for drug trials.

    Source:

  • Jul 29, 2026, 12:48 UTC

    Processa Pharmaceuticals acquired Vidya Therapeutics in an all-stock deal on Wednesday, gaining access to its lead candidate targeting immune system diseases.

    Source: